Workflow
1
icon
Search documents
科慕申请产生1,1-二氟丙烯方法专利,提供其中间体、组合物及用途
Jin Rong Jie· 2026-02-11 11:18
本文源自:市场资讯 作者:情报员 专利摘要显示,本文提供了用于产生二氟烯烃,特别是二氟丙烯诸如1,1‑二氟丙烯的方法,以及其中间 体、组合物及用途。 声明:市场有风险,投资需谨慎。本文为AI基于第三方数据生成,仅供参考,不构成个人投资建议。 国家知识产权局信息显示,科慕埃弗西有限公司申请一项名为"产生1,1-二氟丙烯(HFO-1252zc)的方 法、其组合物和中间体"的专利,公开号CN121511225A,申请日期为2024年7月。 ...
取消出口关税,企业加速“抢出口”!新材料ETF华夏(516710)上涨1.64%,中材科技涨停
Sou Hu Cai Jing· 2026-02-11 06:17
新材料ETF华夏(516710)紧密跟踪中证新材料主题指数,中证新材料主题指数选取50只业务涉及先进钢 铁、有色金属、化工、无机非金属等基础材料以及关键战略材料等新材料领域的上市公司证券作为指数 样本,以反映新材料主题上市公司证券的整体表现。指数中新材料含量达79.85%,指数维度全市场排 名第一。 每日经济新闻 消息面上,财政部、国家税务总局近日对外发布公告称,自2026年4月1日起,取消249项产品增值税出 口退税,涉及光伏、化工、建材等领域,包括甲醇、六氟磷酸锂、1,2-乙二醇、BDO、PVC等80余种化 工产品。 此次出口退税取消将显著催化短期抢出口行情,并开启化工、光伏产业链中长期供给侧改革与集中度提 升。 2月11日,新材料ETF华夏(516710)上涨1.64%,成分股中材科技、中国巨石涨停,万华化学涨超3%。 ...
第11届生物基大会暨展览丨40+名企已报名DT新叶奖!第二轮报名开启,截止3月13日
DT新材料· 2026-02-10 16:05
关键词| DT新叶奖 ! DT新叶奖 (DT New Leaf Award)是由DT新材料、生物基能源与材料联合举办的全球化、 专业性、综合性奖项,专注于生物基领域创新,被誉为" 生物基行业的奥斯卡 "。 四大奖项 : 创新材料奖、创新应用奖、最具商业价值奖、创新行业解决方案奖。 免费报名截止 : 3月13日。 截止目前,已有 40+家 上市和代表性企业报名参选 2026DT新叶奖 , (点击企业名字,详见独家宣传) : 生物基 材料、制 品和应用 : 万华化学 、 双枪科技 、 裕同科技 、 光华伟业 、 利夫生物 、 中科国生 、 京博中聚 、 播下科技 、树合科技、 和塑 美 、 拜科瑞生物 、 碧嘉材料 、深圳职业技术大学、普拉斯新材、 军安绿色新材料 、漂莱特、碳和新材… 生物基化学品/添加剂/能源 :华润双鹤、 糖能科技 、 聚维元创 、 骐业科技 、 浩森生物 、 华呋新材 、 世倍尔 、麒祥材料、 凤登绿能 、 赛泓环 境 、德渊化工、百葵锐、道生生物、 华澄生物 、博辉合生、唯铂莱、 元一生物 、合碳创物… 解决方案(设备/检测/认证/工艺 ) : 科幂仪器 、 霍桐仪器 、 羽时生物 、 ...
民德电子(300656) - 2026年2月9日投资者关系活动记录表
2026-02-09 10:12
编号:2026-01 证券代码:300656 证券简称:民德电子 深圳市民德电子科技股份有限公司投资者关系活动记录表 (1)纯晶圆代工的商业模式定位:纯晶圆代工模式在行业内属于相对稀缺资源, 功率半导体设计公司的痛点,在于找到可以保障其知识产权安全且能为其提供稳定、 可靠产能的晶圆代工厂;国内大部分功率半导体晶圆厂都是 IDM 模式或半 IDM 模式 (即一部分自主产品,一部分对外代工),很难做到对客户知识产权的充分保障和产 能稳定供应。因此,具备原创设计能力的芯片设计公司非常有意愿与广芯微建立代工 合作。 (2)较高端的工艺平台能力和一体化解决方案:广芯微电子的设备配置在国内 6 英寸功率半导体晶圆厂中具备较强的制造水平,已开发搭建的深沟槽刻蚀工艺、通孔 刻蚀+钨淀积工艺及高能注入机台工艺等核心工艺平台能力属业内较高端的平台,产品 线丰富,尤其在高压、特高压领域具有一定的优势;同时,广芯微和芯微泰克可以为 客户提供正面+背道(超薄、背面加工、重金属掺杂等)一体化的特色工艺全套解决方 案,可覆盖大多数功率半导体器件及功率集成电路产品,并利用自身丰富的经验,赋 能设计公司,减少开发周期。 4、广芯微电子产品下游 ...
中央一号文件点名!生物制造迎历史性机遇,这些企业率先入局!
Xin Lang Cai Jing· 2026-02-06 11:20
近日,2026年中央一号文件发布,这是党的十八大以来第14个指导"三农"工作的中央一号文件,这也是"十五五"首个中央一号文件。 《中共中央 国务院关于锚定农业农村现代化 扎实推进乡村全面振兴的意见》中明确提到: 因地制宜发展农业新质生产力,促进人工智能与农业发展相结合,拓展无人机、物联网、机器人等应用场景,加快农业生物制造关键技术创新。 国务院新闻办公室举行的新闻发布会,则介绍锚定农业农村现代化、扎实推进乡村全面振兴有关情况,并答记者问。 发布会以人工智能为例,表明AI在农业育种、现代种养等领域落地应用,从靠经验种地,到靠数据经营、靠算法增效,加快赋能农业数智化转型。 并表示要抓住这一轮科技革命机遇,促进人工智能与农业发展相结合,拓展无人机、物联网、机器人等应用场景,让更多新质生产力成为现代农业发展 的"新引擎"。 下文中我们将借此机会,接受生物制造作为关键的新质生产力,将为农业生产带来哪些改变?又有哪些中国企业及机构在此深度布局? 不靠天吃饭 端稳"中国饭碗" 2026年,生物制造走到了爆发前夜。 农业生物制造的另一大意义,则是端稳"中国饭碗",解决我国的燃眉之急。 我国是世界最大的大豆消费国,但大豆自给率 ...
重庆啤酒20260204
2026-02-05 02:21
重庆啤酒 20260204 摘要 2025 年公司毛利率显著提升,主要得益于麦芽价格下降,有效降低了 吨成本。尽管全年详细数据尚未披露,但前三季度的数据已显示出这一 趋势,且第四季度作为啤酒淡季,对全年影响较小。 2025 年前三季度,销售费用率和管理费用率略有提升,主要因公司在 第三季度加大了对部分品牌的投入。由于第四季度销量占比小,前三季 度数据更具参考价值,具体情况待年报披露后进一步分析。 2025 年前三季度,高档产品如嘉士伯、乐堡、风花雪月增长强劲,乐 堡和乌苏也实现正向增长,但 1,664 受外部环境影响有所下降。主流产 品受宏观环境影响略有下滑,经济产品保持平稳。 乌苏品牌通过持续品牌投入,如代言人选择和 slogan 推广,以及推出 一升装精酿系列,积极布局非现饮渠道,在即时零售、量贩和大型商超 中表现良好,推动了其正向增长。 公司将继续对乌苏及其他高端产品进行持续品牌投入和创新,丰富产品 矩阵,拓展非现饮渠道,以应对市场变化,确保高端产品持续发展。目 前无法提供具体量化趋势指引,但乌苏一升装产品已展现良好势头。 Q&A 2025 年重庆啤酒在整体平淡的市场环境下取得了不错的业绩,营收微增但规 ...
华光环能20260120
2026-01-21 02:57
Summary of Huaguang Huaneng Conference Call Company Overview - **Company**: Huaguang Huaneng - **Industry**: Hydrogen energy, boiler manufacturing, and power engineering Key Points Hydrogen Energy Business - The main products are 1,000 and 1,500 standard cubic meter alkaline water electrolysis cells, with 4 units delivered in 2024 and a new 500 MW production line established [2][5] - The company is collaborating with Dalian University of Technology to develop membrane technology, which may enhance future bidding advantages [2][5] - Current comprehensive energy consumption is approximately 4.0, which is at a leading level [2][5] - The company has not yet ventured into Proton Exchange Membrane (PEM) technology, preferring Anion Exchange Membrane (AEM) technology due to limited cost reduction potential for PEM [2][7] Boiler Manufacturing and Engineering - The business is divided into three segments: traditional boiler manufacturing, engineering (EPC for power plants and municipal projects), and operation (cogeneration operations) [3][4] - The traditional and environmental boiler segments each account for about 50% of revenue, with a focus on high-efficiency and environmentally friendly products [3][15] - The company is maintaining a micro-profit in the alkaline water electrolysis business through resource sharing with boiler production [2][6] Market Dynamics and Future Outlook - The coal-fired power flexibility transformation market is driven by various factors, including cost reduction, environmental protection, and flexible operation needs [2][10] - The company aims to achieve 500 million to 1 billion yuan in orders by 2026 for flexibility transformation projects [2][11] - The PACS (ionic liquid carbon capture) technology is currently not economically viable for large-scale promotion due to high costs (approximately 300 yuan per ton) [2][13] Financial Performance and Strategy - The company expects stable overall performance in 2025, with no impact from relocation subsidies, and a healthy cash flow with continuous positive net cash inflow [3][18] - The collection ratio has improved due to better management of accounts receivable and payment arrangements [19] - Capital expenditure is projected to remain around 1 billion yuan annually, with a stable dividend policy expected for 2025 [20] Strategic Partnerships - The introduction of strategic investors like the National Adjustment Fund and Zijin Insurance is aimed at leveraging their extensive investment resources in emerging industries [17] Challenges and Considerations - The engineering segment is facing a decline, and the company plans to abandon low-margin projects while focusing on profitable opportunities [16] - The domestic market for waste incineration boilers is contracting, while overseas markets, especially along the Belt and Road Initiative, show growth potential [15] Conclusion - Huaguang Huaneng is strategically positioned in the hydrogen energy and boiler manufacturing sectors, with a focus on innovation and cost efficiency. The company is navigating market challenges while aiming for stable growth and exploring new opportunities in emerging technologies and international markets.
国科军工20260112
2026-01-13 01:10
Summary of Guokexun Military Industry Conference Call Company Overview - Guokexun Military Industry is a mixed-ownership enterprise controlled by the Jiangxi Provincial State-owned Assets Supervision and Administration Commission, formed from the restructuring of five ammunition factories and is now publicly listed [3][4] Core Business Segments - The company’s core business includes: - Ammunition equipment (approximately 70% of revenue) - Missile and rocket solid engines and control products (30-40% of revenue) [2][3] - The ammunition segment is primarily focused on small-caliber ammunition, while the missile and rocket segment is experiencing faster growth and higher profit margins [2][4] Financial Performance and Growth Projections - The missile and rocket solid engine business is expected to generate nearly 400 million yuan in revenue by 2024, with a significant military trade order of 466 million yuan confirmed for 2026 [2][6] - The company has initiated capacity expansion projects exceeding 1 billion yuan, expected to gradually commence production by 2026, aiming for a production capacity of 3 billion yuan in missile and rocket solid engines and control products [2][7] - By 2026, the revenue contribution from missile and rocket solid engines is projected to rise to 55%, while traditional ammunition equipment's share will decline, optimizing the revenue structure and profitability [2][9] Market Position and Competitive Advantages - Guokexun Military Industry has established deep collaborations with several private rocket companies in the commercial aerospace sector, benefiting from the rapid development of this market [2][8] - The company’s solid engine products have higher profit margins compared to traditional ammunition equipment, positioning it favorably in the competitive landscape [8][10] Future Outlook - The company is expected to maintain high growth rates in the missile and rocket solid engine segment, driven by capacity expansion and the ability to secure more commercial aerospace orders [7][12] - The anticipated shift in revenue structure by 2028, where missile and rocket solid engines may surpass traditional ammunition equipment, is expected to further enhance overall profit margins [9][12] Industry Trends - The commercial aerospace market is currently booming, with many private companies still utilizing a hybrid approach of solid and liquid propulsion systems, allowing Guokexun Military Industry to leverage its unique production capabilities during this transitional phase [10][11]
重庆啤酒20260105
2026-01-05 15:42
Summary of the Conference Call for Chongqing Beer (2025) Industry Overview - The beer industry is experiencing a shift towards non-consumption channels, with companies actively developing these avenues due to weak performance in on-premise sales [2][3][4]. Key Points Company Initiatives - Carlsberg China is launching new products in 2025, including special packaging for the Spring Festival and commemorative cans for Liverpool's UEFA Champions League victory [2][3]. - The company is exploring new product categories beyond beer, such as energy drinks and carbonated beverages [2][3]. - The non-consumption channel is projected to account for approximately 56%-57% of overall sales in 2025, maintaining a stable share compared to previous years [2][6]. Sales Performance - In the first three quarters of 2025, premium product sales showed growth, with Carlsberg and Fenghua Xueyue brands achieving double-digit growth [2][5]. - The company’s filling rate is expected to increase from 18%-19% in 2023 to around 29% by the end of 2025, with a target to reach the industry average of 35%-40% in the future [2][7]. Regional Market Insights - The Xinjiang market is performing well, driven by tourism and optimized brand structure for the Wusu brand [2][10]. - However, the Chongqing and Yunnan regions have seen a decline due to external environmental factors, although the Fenghua Xueyue brand has performed well in traditional and low-alcohol beer segments [2][10][11]. Cost and Profitability - The company anticipates a cautious outlook for gross margins due to rising aluminum can prices and a slower decline in raw material costs [3][18]. - The effective tax rate has increased from 19-20% in 2024 to nearly 24% in the first three quarters of 2025, with expectations to maintain this level in 2025 and 2026 [3][17]. Future Outlook - The company plans to continue focusing on non-consumption channels and product innovation, with collaborations with platforms like JD.com and Waimai Songjiu for customized products [3][14][15]. - A stable high dividend policy will be maintained, reflecting the company's commitment to shareholder returns [3][19]. Additional Considerations - The company is not considering outsourcing production but prefers to maintain brand integrity through customized product offerings [3][15]. - The impact of a one-time litigation cost from the previous year is expected to affect net profit by approximately 10 million to over 9 million [3][16]. - Preparations for the Spring Festival include launching new promotional products and marketing campaigns [3][20].
华润双鹤5亿元产业基金完成备案,全面助力合成生物第二增长曲线
Group 1 - The establishment of the "China Resources Double Crane Biopharmaceutical Industry Fund" with a scale of 500 million yuan focuses on key technologies and high-tech achievement transformation projects in synthetic biology and related fields [1] - This fund is the first industry fund of China Resources Group dedicated to synthetic biology, aligning with the group's strategic initiative in emerging industries [1][3] - The company aims to create a second growth curve through synthetic biology, promoting significant development during the 14th Five-Year Plan period [1][3] Group 2 - China Resources Double Crane has over 80 years of experience in the pharmaceutical industry and operates 24 subsidiaries with approximately 13,000 employees, achieving annual sales exceeding 10 billion yuan [3] - The company has set two strategic goals for the 14th Five-Year Plan: to establish its core chemical drug business as "China's leading prescription drug brand" and to leverage synthetic biology technology for new growth [3] - The company’s subsidiary, Shenzhou Biotechnology, is a key platform for the industrialization of synthetic biology, with its core product, coenzyme Q10, holding the second-largest global market share [3] Group 3 - Synthetic biology is leading a global biotechnological revolution with vast market potential across various sectors, including food, healthcare, biomaterials, green agriculture, and personal care [4] - The fund will complement the company's external mergers and acquisitions, facilitating early-stage project innovation and integration with invested companies in technology, production, and market aspects [4] - The collaboration between China Resources Double Crane and the Hohhot municipal government will enhance the competitiveness of the synthetic biology industry, leveraging local resource advantages for large-scale fermentation production [4]